BHCM
ORGO icon

Brevan Howard Capital Management’s Organogenesis Holdings ORGO Stock Holding History

Brevan Howard Capital Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-91,033
Closed -$472K – 2389
2025
Q4 		$472K Buy
+91,033
New +$441K 0.01% 1146

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Brevan Howard Capital Management's ORGO Position: Q1 2026 in Review

Brevan Howard Capital Management sold out of Organogenesis Holdings (ORGO) in Q1 2026, closing a stake of 91,033 shares — an estimated $472K sold.

Brevan Howard Capital Management first reported a position in ORGO in Q4 2025 and held it in 1 quarter. The position peaked at $472K in Q4 2025. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

  • Brevan Howard Capital Management reported no remaining Organogenesis Holdings position as of Q1 2026 after selling out during the quarter.
  • Brevan Howard Capital Management sold 91,033 Organogenesis Holdings shares in Q1 2026, an estimated $472K.
  • Brevan Howard Capital Management first reported a position in Organogenesis Holdings in Q4 2025 and held it in 1 quarter.
  • Brevan Howard Capital Management's Organogenesis Holdings position peaked at $472K in Q4 2025.
  • 121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.